The amount of administered therapeutic medicine that is absorbed in site of drug action Blood concentrations of the active ingredients and their active metabolites will provide a marker for the concentration at the site of action with a valid measure of bioavailability Two drugs comprising identical active ingredients, otherwise two different dosage forms of the same investigational product possess similar bioavailability and produce the same effect at the site of action of Bioequivalence
Related: Clinical Trials Conferences| Clinical TrialConferences | Pharmacovigilance Conferences | Clinical Trials Congress |ClinicalTrials Meetings | MedicalConferences | PharmacologyConferences | ClinicalResearch Conferences | Clinical research Society | Clinical Research Associations
Recommended: 9th World Congress on Clinical Pharmacyand Pharmacy Practice Amsterdam, Netherlands March 25-26, 2019, 4thInternational Conference onMedical Microbiology 2019 Vienna, Austria May 20-21, 2019, CPD Accredited8th European ClinicalMicrobiology and ImmunologyCongress Edinburgh, Scotland June 12-13, 2019, International Conference on Clinical Trials& Pharmacovigilance,Prague Czech Republic, September 23 -24 2019. World Congress on Biomarkers andClinical Research, Tokyo, Japan, August 5-6, 2019.
Related Associations: BelgianSociety of Pharmaceutical Sciences (BGFW), EuropeanFederation for Pharmaceutical Sciences (EUFEPS),ItalianSociety for Pharmaceutical Sciences (SISF), Associationof the British Pharmaceutical Industry (ABPI), InternationalPharmaceutical Federation (FIP)
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
